Compound 926
Identifiers
- Canonical SMILES:
CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)N2CCC(CC2)C(O)=O)c(Cl)c1Cl
- IUPAC name:
1-[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]piperidine-4-carboxylic acid
- InChi:
InChI=1S/C25H27Cl2NO3S/c1-14(2)16-5-3-4-6-20(16)32-21-8-7-17(22(26)23(21)27)18-13-19(18)24(29)28-11-9-15(10-12-28)25(30)31/h3-8,14-15,18-19H,9-13H2,1-2H3,(H,30,31)/t18-,19+/m0/s1
- InChiKey:
MEMSOGHDJLMQDL-RBUKOAKNSA-N
External links
91045101 |
19174414 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 8.05 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 491.11 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 6.33 | |||
TPSA | 57.61 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5391 | Tedatioxetine | DB12641 | |
0.5167 | Mitiglinide | DB01252 | |
0.5000 | 6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid | DB03471 | |
0.4922 | Metixene | DB00340 | |
0.4741 | WRR-99 | DB03573 | |
0.4741 | WRR-112 | DB03691 | |
0.4692 | NS-2359 | DB05805 | |
0.4656 | Kelatorphan | DB08040 | |
0.4643 | AMG-232 | DB15299 | |
0.4628 | Amitifadine | DB05964 | |
0.4627 | GSK-424887 | DB12219 | |
0.4625 | N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide | DB08429 | |
0.4586 | Enalaprilat | DB09477 | |
0.4552 | Tesofensine | DB06156 | |
0.4520 | SR 140333 | DB05790 |